NCT00212368View on ClinicalTrials.gov

Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

December 31, 2005

Conditions
Wison's Disease
Interventions
DRUG

Zinc acetate

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT00212368 - Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan. | Biotech Hunter | Biotech Hunter